Kaplan J E, Schonberger L B, Hurwitz E S, Katona P
Neurology. 1983 May;33(5):633-7. doi: 10.1212/wnl.33.5.633.
During the period January 1978-March 1981, 2,575 cases of Guillain-Barré syndrome (GBS) were reported by participating neurologists in the national GBS surveillance system. The incidence of GBS was highest in the 50- to 74-year-old age group, but a lesser peak was observed in persons aged 15 to 35. The frequencies of antecedent respiratory (43%) and gastrointestinal (21%) illness exceeded frequencies of such illnesses in the US population (10 and 0.8%, respectively), based on survey data compiled by the National Center for Health Statistics; the differences in these frequencies of illness were similar in all seasons of the year, in males and in females, and in persons less than 6, 6 to 16, 17 to 44, and greater than 44 years of age. Nineteen percent of adult patients for whom information was available (67% of the total) reported receiving an A/New Jersey influenza vaccine in 1976, a lower percentage than would be expected on the basis of a survey conducted in that year. The data suggest that persons who received this vaccine have not been at increased risk and may even have been at decreased risk of acquiring GBS during the period covered by this study.
在1978年1月至1981年3月期间,参与全国格林-巴利综合征(GBS)监测系统的神经科医生报告了2575例GBS病例。GBS发病率在50至74岁年龄组中最高,但在15至35岁人群中也观察到一个较小的峰值。根据美国国家卫生统计中心汇编的调查数据,前驱呼吸道疾病(43%)和胃肠道疾病(21%)的发生频率超过了美国人群中此类疾病的发生频率(分别为10%和0.8%);这些疾病发生频率的差异在一年中的所有季节、男性和女性以及年龄小于6岁、6至16岁、17至44岁和大于44岁的人群中均相似。在有信息可查的成年患者中,19%(占总数的67%)报告在1976年接种了A/新泽西流感疫苗,这一比例低于当年一项调查预期的比例。数据表明,接种该疫苗的人群在本研究涵盖的期间内患GBS的风险并未增加,甚至可能有所降低。